首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation
Authors:Luginbühl Béatrice  Kanyo Zoltan  Jones R Mark  Fletterick Robert J  Prusiner Stanley B  Cohen Fred E  Williamson R Anthony  Burton Dennis R  Plückthun Andreas
Institution:Biochemisches Institut, Universit?t Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Abstract:Bovine spongiform encephalopathy (BSE) is a fatal neurodegenerative prion disease affecting cattle that is transmissible to humans, manifesting as a variant of Creutzfeldt-Jakob disease (vCJD) likely following the consumption of meat contaminated with BSE prions. High-affinity antibodies are a prerequisite for the development of simple, highly sensitive and non-invasive diagnostic tests that are able to detect even small amounts of the disease-associated PrP conformer (PrP(Sc)). We describe here the affinity maturation of a single-chain Fv antibody fragment with a binding affinity of 1 pM to a peptide derived from the unstructured region of bovine PrP (BoPrP (90-105)). This is the tightest peptide-binding antibody reported to date and may find useful application in diagnostics, especially when PrP(Sc) is pretreated by denaturation and/or proteolysis for peptide-like presentation. Several rounds of directed evolution and off-rate selection with ribosome display were performed using an antibody library generated from a single PrP binder with error-prone PCR and DNA-shuffling. As the correct determinations of affinities in this range are not straightforward, competition biosensor techniques and KinExA methods were both applied and compared. Structural interpretation of the affinity improvement was performed based on the crystal structure of the original prion binder in complex with the BoPrP (95-104) peptide by modeling the corresponding mutations.
Keywords:BoPrP  bovine prion protein  BSE  bovine spongiform encephalopathy  Cam  chloramphenicol  chFab  mouse/human chimeric Fab fragment (V domains are murine  C domains are human)  CDI assay  conformation-dependent immunoassay  CDR  complementarity-determining region  CJD  Creutzfeldt-Jakob disease  CWD  chronic wasting disease  dNTPs  deoxynucleoside triphosphate  8-oxo-dGTP  8-oxo-2′-deoxyguanosine triphosphate  dPTP  D-ribofuranosyl)-3" target="_blank">6(2-deoxy-β-D-ribofuranosyl)-3  4-dihydro-8H-pyrimido[4  5-c][1  2]-oxazin-7-one-triphosphate  GSS  Gerstmann-Sträussler-Scheinker syndrome  IPTG  isopropylthiogalactoside  KinExA  kinetic exclusion assay  PDEA  2-(2-pyridinyldithio)ethaneamine hydrochloride  MBo2Mo  mouse/bovine chimeric prion protein (residues 23-231 are mouse  except for residues 90-144  which are bovine)  MoPrP  mouse prion protein  PrPC  cellular prion protein  PrPSc  disease-associated isoform of prion protein  scFv  single-chain Fv fragment  ELISA  enzyme-linked immunosorbent assay  SPR  surface plasmon resonance  RIA  radioimmunoassay  RT  room temperature  TSE  transmissible spongiform encephalopathy  VL  variable light chain domain  VH  variable heavy chain domain
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号